ReviewFrontiers in cellular and infection microbiology2025
The necessity and challenges of human papillomavirus testing for men.
Review in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cervical Cancer Screening in Transition: Global Challenges and Local Realities.International journal of women's health · 2026Review
- Primary and Secondary Prophylaxis for Diseases Caused by Human Papillomavirus Infections.Journal of cancer prevention · 2025Review
- A Cross-Sectional Look at HPV Vaccine Acceptance and Associated Factors Among Male University Students in Lebanon.Advances in urology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Beyond its historical association with cervical cancer in women, human papillomavirus (HPV) infection poses a widespread health concern, particularly for men. Recent studies have highlighted the prevalence of HPV-related cancers, including penile and anal cancers, among the male population, making the case for male HPV testing all the more compelling. The potential for cross-infection between sexual partners underscores the need for comprehensive screening strategies. However, challenges still remain, such as the limited availability of testing methods and the absence of uniform medical guidelines, hampering effective HPV detection in men. Addressing these challenges through intensified research efforts and the revision of medical guidelines is crucial to enhancing prevention strategies and unlocking significant public health benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.